Advanced Medical Solutions Grp PLC Trading Update (9919J)
July 04 2017 - 2:00AM
UK Regulatory
TIDMAMS
RNS Number : 9919J
Advanced Medical Solutions Grp PLC
04 July 2017
4 July
Advanced Medical Solutions Group plc
("AMS" or the "Group")
Trading Update
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS),
the surgical and advanced wound care specialist company, today
announces a trading update covering the six-month period 1 January
to 30 June 2017.
The Group continues to make good progress and can confirm that
trading for the six-month period is in line with the Board's
expectations.
Chris Meredith, Chief Executive Officer of AMS, commented: "The
Board is pleased with the ongoing strong performance of the
business and we are on track for the full year. We remain focused
on our strategic objectives to grow organically and through
acquisition, whilst delivering innovation that will benefit both
patients and surgeons."
The Group expects to publish its Interim Results for the period
to 30 June 2017 on 13 September 2017.
For further information, please visit www.admedsol.com or
contact:
Advanced Medical Solutions Group Tel: +44 (0)
plc 1606 545508
Chris Meredith, Chief Executive
Officer
Mary Tavener, Group Finance Director
Consilium Strategic Communications Tel: +44 (0)
20 3709 5700
Mary-Jane Elliott / Jonathan
Birt / Matthew Neal / Hendrik
Thys
Investec Bank PLC (NOMAD & Broker) Tel: +44 (0)
20 7597 5970
Daniel Adams / Patrick Robb
About Advanced Medical Solutions Group plc - see
www.admedsol.com
AMS is a world-leading independent developer and manufacturer of
innovative and technologically advanced products for the global
surgical and wound care markets, focused on quality outcomes for
patients and value for payors. AMS has a wide range of wound care
products that include silver alginates, alginates, foams, tissue
adhesives, sutures and haemostats, which it sells under white label
as well as its own brand ActivHeal(R), and surgical tissue
adhesives, sutures and haemostats, which markets under its own
brands; LiquiBand(R) and RESORBA(R).
AMS's products, manufactured out of two sites in the UK, one in
the Netherlands, two in Germany and one in the Czech Republic, are
sold in more than 75 countries via a network of multinational or
regional partners and distributors, as well as via AMS's own direct
sales forces in the UK, Germany, the Czech Republic and Russia.
Established in 1991, the Company has 600 employees. For more
information, please see www.admedsol.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
TSTLLFFRDAIVIID
(END) Dow Jones Newswires
July 04, 2017 02:00 ET (06:00 GMT)
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2023 to Apr 2024